File Download

There are no files associated with this item.

Supplementary

Conference Paper: Portending the future: How will a positive 1st line trial with check-point inhibitors in HCC change the treatment paradigm in HCC

TitlePortending the future: How will a positive 1st line trial with check-point inhibitors in HCC change the treatment paradigm in HCC
Authors
Yau, TCC
Issue Date2019
Citation
6th Asia-Pacific Gastroenterology Cancer Summit (APGCS) 2019, Singapore, 4-5 May 2019 How to Cite?
DescriptionSession III : Personalizing Therapy for HCC
Persistent Identifierhttp://hdl.handle.net/10722/281134

 

DC FieldValueLanguage
dc.contributor.authorYau, TCC-
dc.date.accessioned2020-03-06T08:56:49Z-
dc.date.available2020-03-06T08:56:49Z-
dc.date.issued2019-
dc.identifier.citation6th Asia-Pacific Gastroenterology Cancer Summit (APGCS) 2019, Singapore, 4-5 May 2019-
dc.identifier.urihttp://hdl.handle.net/10722/281134-
dc.descriptionSession III : Personalizing Therapy for HCC-
dc.languageeng-
dc.relation.ispartof6th Asia-Pacific Gastroenterology Cancer Summit (APGCS) 2019-
dc.titlePortending the future: How will a positive 1st line trial with check-point inhibitors in HCC change the treatment paradigm in HCC-
dc.typeConference_Paper-
dc.identifier.emailYau, TCC: tyaucc@hku.hk-
dc.identifier.authorityYau, TCC=rp01466-
dc.identifier.hkuros308544-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats